computer-based fitting program prism (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
computer-based fitting program prism
Computer Based Fitting Program Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+computer+fitting+program/prism+computer+fitting+program/pmc10709667-178-8-12
Average 90 stars, based on 1 article reviews
Computer Based Fitting Program Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+computer+fitting+program/prism+computer+fitting+program/pmc10709667-178-8-12
Average 90 stars, based on 1 article reviews
computer-based fitting program prism - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Effect of total dissolved gas supersaturation and flow velocity on survival and swimming ability of juvenile Schizothorax prenanti Article Snippet: Data from tolerance experiments were processed by the Article Title: Protective Effect of Eichhornia Crassipes Against Cerebral Ischemia Reperfusion Injury in Normal and Diabetic rats. Article Snippet: rnal of Stroke and Cer Eichhornia crassipes (EC) is well reported to modify inflammatory response, oxidative stress which are key pathophysiological finding of cerebral reperfusion injury, alongside it is reported to reduce cholesterol and blood glucose levels, and therefore present work was designed to investigate the effect of EC on cerebral reperfusion injury in normal and diabetic rats.. Each protocol comprised cerebral ischemia (CI) for 30 min followed by reperfusion(R) for 1 h. Animals were treated with EC (100 mg/kg p.o) for seven days.. At the end of the experiment, brain tissue was utilized for the measurement of oxidative stress markers, inflammatory response, infarct size and histopathological findings. Article Title: Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety. Article Snippet: Statistical significance between groups are compared using unpaired two-tailed student’s t-test or one-way ANOVA as appropriate using Article Title: Methods and compositions for the rapid synthesis of radiometal-labeled probes Article Snippet: The IC50 values were calculated by nonlinear regression analysis using the Article Title: Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling. Article Snippet: Accepted Manuscript Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling Bhavesh C Variya , Anita K Bakrania , Snehal S Patel PII: S0944-7113(19)30076-5 DOI: https://doi.org/10.1016/j.phymed.2019.152906 Article Number: 152906 Reference: PHYMED 152906 To appear in: Phytomedicine Received date: 22 January 2019 Revised date: 28 March 2019 Accepted date: 30 March 2019 Please cite this article as: Bhavesh C Variya , Anita K Bakrania , Snehal S Patel , Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling, Phytomedicine (2019), doi: https://doi.org/10.1016/j.phymed.2019.152906 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Article Title: The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons. Article Snippet: Accepted Manuscript The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons Carlo Matera, Federica Bono, Silvia Pelucchi, Ginetta Collo, Leonardo Bontempi, Cecilia Gotti, Michele Zoli, Marco De Amici, Cristina Missale, Chiara Fiorentini, Clelia Dallanoce PII: S0006-2952(19)30057-7 DOI: https://doi.org/10.1016/j.bcp.2019.02.019 Reference: BCP 13425 To appear in: Biochemical Pharmacology Received Date: 10 December 2018 Accepted Date: 13 February 2019 Please cite this article as: C. Matera, F. Bono, S. Pelucchi, G. Collo, L. Bontempi, C. Gotti, M. Zoli, M. De Amici, C. Missale, C. Fiorentini, C. Dallanoce, The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons, Biochemical Pharmacology (2019), doi: https://doi.org/10.1016/j.bcp.. 2019.02.019 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats Article Snippet: Statistical significance between more than two groups was tested using one-way ANOVA followed by the Bonferroni multiple comparisons test as appropriate using Article Title: Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker. Article Snippet: The IC50 values were calculated by nonlinear regression analysis using the |